COURSE PRICE: $10.00
CONTACT HOURS: 1
Wild Iris Medical Education is an approved provider of continuing education by the American Occupational Therapy Association (AOTA), Provider #3313. Courses are accepted by the NBCOT Certificate Renewal program.
Content Focus
Domain of OT: Client Factors
OT Process: Outcomes
The planners and authors of this CE activity have disclosed no relevant financial relationships with any commercial companies pertaining to this activity.
Persis Mary Hamilton has a rich background in nursing, nursing education, and writing. She has written fourteen nursing textbooks for two major publishers. Her doctoral dissertation investigated the relationship of learning to behavioral objectives and visual design in a textbook. Persis Hamilton works with Wild Iris Medical Education to ensure compliance with American Nurses Credentialing Center accreditation guidelines. She is involved with assessing needs, planning, implementing, and evaluating all nursing continuing education activities offered by the company. Over the years Hamilton has worked in most areas of nursing. She taught for more than 40 years in vocational, associate degree, baccalaureate degree, and graduate nursing programs, served as item writer for the League for Nursing, and was the principle speaker at numerous continuing education workshops. In addition, she has conducted research in Micronesia as well as Guam. Currently, Persis maintains a private practice in psychotherapy. Recently she completed a historical novel about the care of psychiatric patients in the 1930's, entitled Deportation Train.
Copyright © 2005 Wild Iris Medical Education, Inc. All Rights Reserved.
Upon completion of this course, you will be able to:
To many people, the word cancer means pain and death. Sadly, there is much to support their point of view. One study found that 30% of clients experience pain at the time of diagnosis, 30% to 50% experience pain while undergoing therapy, and 70% to 90% experience pain as cancer advances and overcomes their defenses (Portenoy & Lesage, 1999). Yet, a decade ago, the World Health Organization (WHO) reported that 90% of cancer clients could receive adequate pain relief with relatively simple drug therapy then available (WHO, 1996). Since then, even more pain-relieving treatments have been developed. To achieve the goal of providing adequate pain relief for people with cancer and for all who are dying, healthcare providers need to understand the causes and types of cancer pain, the impact of pain, and effective strategies to manage pain.
Cancer pain is complex, interactive, and ever-changing. It comes from two general sources: the cancer itself, and its various treatments. As cancer cells invade healthy tissue, visceral and somatic nociceptors sense tissue damage and send impulses to the brain, where the individual perceives pain. Such pain may be localized at the cancer site or referred to a remote area. Not only do sensory impulses inform the person of tissue injury, they initiate the release of neuromodulators that produce localized inflammation and generate more pain. As nervous tissue is infiltrated by tumor growth or damaged by its treatment, neuropathic pain results, often persisting long after the initial insult. In addition to physical pain, people with cancer and their families experience the emotional pain of anticipatory grief and the stress and fear of cancer and its treatment. Thus, cancer causes many kinds of pain: nociceptor, neuropathic, psychogenic, and secondary:
Pain caused by cancer depends on the site and extent of growth. Often tumors produce clusters of symptoms, or syndromes. Some common cancer pain syndromes and a description of the typical pain they create are listed below.
| Cancer Pain Syndromes | Typical Pain |
|---|---|
| Peripheral nerve syndromes | Constant, burning pain with dysesthesia in area of sensory loss; radiating, and often unilateral |
| Cranial neuropathies | Severe head pain with cranial nerve dysfunction; metastasis to skull base and leptomeningeal area |
| Vertebra of spine | Constant dull, aching pain; may be relieved by standing or exacerbated by recumbency |
| Bone: metastatic or primary | Aching, deep, intense pain, usually worse at night; pain may be referred; associated muscle spasm and stabbing pain with nerve involvement |
| Viscera | Pain in related area: pancreatic pain is relentless, boring, mid-epigastric, radiating through to the mid-back |
Plexopathies
|
Aching and diffuse in shoulder girdle and radiating Heaviness and tightness in upper arm, radiating Aching, pressure-like, may be referred to abdomen, buttocks, lower back, or legs |
Modern medicine treats cancer with potent chemicals, radiation, and surgery, each of which can cause pain; they destroy healthy cells as well as cancer cells, and their side effects also cause pain. Some side effects include incisional pain from surgery, emesis from chemotherapy, and stomatitis from radiation. Sweeder (2002) estimated that 20% to 25% of the pain of cancer clients is directly related to its treatment. The table below lists some common syndromes that result from treatment modalities and the typical pain and complications that result.
| Syndromes | Typical Pain and Complications |
|---|---|
| Postoperative Pain Syndromes | Incision pain; sharp and burning |
| Mastectomy | Tight, constricting, burning in back of arm, axilla, over chest, worse on movement; tingling in distribution of peripheral nerves; loss of sensation |
| Axillary lymphectomy | Numbness and aching due to edema |
| Thoracotomy | Referred pain to arm and chest, sensory loss around scar; reflex sympathetic dystrophy may develop |
| Amputation | Phantom pain in place of missing limb or body part |
| Radical neck dissection | Tight burning sensation in the neck and numbness or prickly sensation in the neck; dysesthesia in area of sensory loss |
| Oophorectomy | Surgical menopause, hot flashes |
| Postradiation Pain Syndromes | Aching pain, similar to postoperative and tumor pain; radiation may cause new neurogenic tumors and soft-tissue fibrosis |
| Myelopathy | Aching or shooting pain in certain muscles |
| Necrosis of bone | Aching, prickling; may be localized or referred |
| Mucositis and stomatitis | Ulcers of the mucus membrane; raw, burning sensation; eating and drinking made painful |
| Postchemotherapy Pain Syndromes | Some drugs (vesicants) seriously damage tissue if they leak outside blood vessels (extravasation); most cause nausea and vomiting |
| Mucositis and stomatitis | Painful ulcers of the mucous membrane are the most common complication of chemotherapy, especially from methotrexate, doxorubicin, daunorubicin, bleomycin, etoposide, fluorouracil, and dactinomycin; appears about 10 days after beginning of treatment; pain on eating or drinking |
| Aseptic necrosis of the bone | Jaw pain; intermittent calf pain and/or prickling in hands or feet |
| Painful polyneuropathy | May feel pain in several places at once |
| Steroid pseudorheumatism | Aching pain in joints |
| Chemical menopause for estrogen-positive breast cancer | Hot flashes from tamoxifen, an anti-estrogen |
| Pain due to tests and devices | Sharp, piercing pain from needle sticks; abdominal distention from cleansing enemas and colonoscopies; discomfort from exposure; squeezing from machines; burning from extravasation of IV drugs |
In addition to pain, some of the more troubling physical side effects of cancer and its treatment are emesis, constipation, pneumonia, and pressure sores.
Emesis is such a common complication of chemotherapy that oncology nurses have identified four types:
The vomiting center in the medulla oblongata in the brain coordinates the act of vomiting from several pathways, including the neurotransmitter receptors in the gastrointestinal tract, vagal and spinal sympathetic nerves, and chemical stimuli in the viscera and blood ( Haughney, 2004). Vomiting is controlled by a complex interaction between serotonin and dopamine receptor sites and neurotransmitters. The most effective way to prevent emesis is to antagonize serotonin receptors, using selective 5-HT receptor antagonists such as ondansetron (Zofran), granisetron ( Kyril), and dolasetron (Anzemet). Available in both oral and injectable form, these drugs block serotonin receptors in the gastrointestinal tract and are reported to prevent emesis in 70% to 90% of clients (Roux, 2002).
Constipation is a common cause of pain in cancer clients, not only as a side effect of opioid pain medications, but also because of immobility and inadequate fluid and fiber intake. To prevent these complications, oncology nurses recommend a bowel care program that includes the following:
While saline and mineral oil laxatives may be needed occasionally, they are not recommended on a regular basis. Bulk-forming and stool softening laxatives can be used safely for extended periods of time. A practical protocol to manage opioid-induced constipation in cancer clients was developed by Robinson and colleagues. It combines senna (a stimulant) and docusate sodium (a stool softener), titrating the dose to the client's needs (Robinson CB, 2000). Other management suggestions include:
Pneumonia is not usually associated with pain, or cancer. However, when debilitated cancer clients undergo surgery or chemotherapy, they are less likely to cough and to breathe deeply. When mucus collects in the airways, pathogens grow, and pneumonia results. To prevent this painful and life-threatening complication, nurses encourage mobility, hydration, deep breathing, and use of incentive spirometers or balloon blowing.
Pressure sores (decubiti) are painful erosions of the skin caused by cell death due to inadequate oxygen and nutrients. These erosions expose nerves and invite infection. Because weakened cancer clients are ill-equipped to fight infection, prevention is essential. This requires constant monitoring, frequent turning, protection from trauma, and relief of pressure. If decubiti develop, they must be treated promptly and vigorously.
Cancer pain is more than a physical symptom. It is a reminder of ones mortality and a harbinger of death. It interferes with normal routines, degrades the quality of life, and robs one of rest, creativity, joy, and peace. Cancer pain adds stress and worry to its sufferers and friends and family. For this reason, healthcare professionals:
The management of cancer-related pain is complicated when sufferers have pre-existing chronic pain, a history of substance abuse, or are near death. For this reason accurate assessment is essential, especially of "new pain." Nurses may find the acronym OLDCART a useful tool as they assess pain:
Cancer is treated with both pharmacologic and nonpharmacologic therapies. Pharmacologic remedies include non-opioid analgesics, opioid analgesics, and co-analgesics or adjuvants. Unlike postoperative or post-trauma pain, cancer pain may go on for months and years, add to existing chronic pain, and become more intense as the client undergoes treatment or as the cancer invades other tissues.
To guide caregivers, the American Pain Society identified the thirteen principles regarding the use of analgesics to control pain:
The focus of pain management at the end of life is to provide support and comfort, rather than cure, for the dying and those they leave behind. To do this, caregivers need to understand the concepts, guidelines, ethical concerns, and legal issues associated with the end of life.
Palliative care is the active, total care of clients with a goal of providing comfort rather than cure (WHO, 2000). It addresses pain control, symptom management, and social, emotional, spiritual, and financial concerns of people at the end of life.
Cicely Saunders was a nurse, social worker, and physician when in 1968 she opened St. Christopher's Hospice in England to care for people who were dying alone and in pain. She developed the concept of enhancing the quality of life through palliative care rather than curative treatment. Hospice came to the United States in the 1970s as a philosophy rather than a place, and since that time has spread throughout the nation, addressing the needs of people whose life is ending.
Suffering is a highly personal experience that depends on the meaning an event, such as an illness or loss. One can suffer without physical pain and one can have physical pain and not necessarily suffer. The founder of the modern hospice movement described suffering as "total pain," an experience of changing self-perception, fear of physical distress and dying, concerns about relationships, changing self-perception, and memory of other person's suffering (Panke, 2002).
Quality refers to a measure or a grade of something. Quality of life refers to the state or condition of ones' being. If people are physically comfortable and emotionally satisfied, we say their quality of life is good. If they are in pain, under stress, alone, sad, or distressed, as many people are, we say their quality of life is poor. The goal of hospice and palliative care is to enhance the quality of life of dying clients.
To help caregivers provide better care to individuals in pain and at the end of life, Paice and Fine (2001) suggest the following guidelines:
Ethical and legal issues at the end of life care are often intertwined (Scanlon 2003). This is especially true because of the pain that frequently accompanies terminal illnesses, as with cancer and HIV-AIDS. Therefore, it is vital for all healthcare facilities to anticipate potential conflicts and see that advance directives are in place. When they are not, healthcare professionals may believe they are legally required to continue medically provided nutrition and hydration even when a client no longer benefits.
To resolve this conflict, all fifty states and the District of Columbia have enacted statutes to comply with the Client Self Determination Act (Omnibus Budget Reconciliation Act of 1990). The federal law requires that all healthcare institutions receiving Medicare and Medicaid funding must inform clients in writing about their right under state law to accept or refuse medical or surgical treatment before they become incapacitated. Legal forms called advance directives facilitate this legislation. Instructions and forms for each state are available free at the website of Partnership for Caring: www.partnershipforcaring.org/advance/adconfirm.php.
There are two basic types of advance directives: living wills (treatment directives) and durable power of attorney for healthcare (appointment directives) as follows:
Despite legislation, Last Acts found that only 15% to 20% of the general population had an advance directive. They also found that decision making was skewed by circumstances at the moment and that nurses play a vital role in helping families come to terms with the impending death of a loved one because nurses are the first to recognize signs of approaching death (Partnership for Caring, 2002).
Communication strategies nurses can use to help terminally ill clients and their families make decisions about end-of-life care were suggested by Norton and Talerico (2001):
Ethical principles guide nurses at every stage of life, including its end. In particular, nurses and all healthcare professionals follow the basic ethical principles of respect for human life and dignity, beneficence, autonomy, honesty, and justice. In sum, pain management at its best provides maximum pain relief and minimal harm to people at every stage of life, including its end.
American Pain Society. (2005). Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed. Glenview, IL: author.
Bednash G, Ferrell BR. (2002). Pain and Symptom Management in End of Life Care. Sacramento: CME.
Haughney A. (2004). Nausea and vomiting in end-stage cancer. American Journal of Nursing 104(11):41–48.
Haylock PJ, Curtiss CP. (1997). Cancer Doesn't Have to Hurt. Alameda, CA: Hunter House.
Norton SA, Talerico KA. (2000). Facilitating end of life decision-making: Strategies for communicating and assessing. Journal of Gerontology Nursing 26(9):126–34.
Paice JA, Fine BR. (2001). Pain at the end of life. In Textbook of Palliative Medicine, B. Ferrell and N. Coyle (eds.). (pp. 76–90). Oxford: Oxford University Press.
Panke JT. (2002). Difficulties in managing pain at the end of life. American Journal of Nursing 102 (7):26–33.
Partnership for Caring. (2001). Glossary of Terms. Retrieved from http://www.partnershipforcaring.org/advance/adconfirm.php.
Portenoy R, Lesage P. (1999). Management of cancer pain. Lancet 353:1695–1700.
Robinson CB, et al. (2000). Development of a protocol to prevent opioid-induced constipation in clients with cancer: A research utilization project. Clinical Journal of Oncology Nursing 4(2)79–84.
Roux G. (2002). Breast Cancer Care. Sacramento: CME.
Saunders C. (1970). Nature and management of terminal pain. In Matters of Life and Death, E. Shorter (ed.). (pp. 15–26). London: Darton Longman & Todd.
Scalon C. (2003). Ethical concerns in end-of-life care. American Journal of Nursing 103(1) 48–55.
Sweeder J. (2002). Educating clinicians on effective pain management. The Pain Clinic 4(1):11–19.
World Health Organization (WHO). (1996). Cancer Pain Relief with a Guide to Opioid Availability, 2nd ed. Geneva: Author.
TherapyCEU.com is a division of Wild Iris Medical Education
Copyright © 1999-2009 Wild Iris Medical Education, Inc.
Photograph © 2008 Jon Klein
Get discounts, special offers, and information.
We do not sell, rent, or share our mailing list.